CD8A and cancer: Notably, repeated exposure to cognate viral-antigen makes CD8+ T cells more sensitive to antigen-independent bystander activation in cancer, suggesting that CD8+ T cells responsive to common human viruses, such as CMV, EBV and influenza, may be the best targets to boost antitumor immunity (176).